FDA Approves Postpartum Depression Drug That’s Both Exciting and Super Frustrating

The Food and Drug Administration announced Tuesday, March 19 that it has approved a drug specifically designed to treat postpartum depression in new mothers. The approval for Zulresso (brexanolone) signals the first time in history that a drug for postpartum depression will be made available to the …